Interferon-gamma levels in nasopharyngeal secretions of infants with respiratory syncytial virus and other respiratory viral infections.
about
Brief History and Characterization of Enhanced Respiratory Syncytial Virus DiseaseImmune responses and disease enhancement during respiratory syncytial virus infectionTRIF Deficiency does not Affect Severity of Ovalbumin-induced Airway Inflammation in Mice.Animal models of human respiratory syncytial virus diseaseLocal interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze.Differential mucin expression by respiratory syncytial virus and human metapneumovirus infection in human epithelial cells.Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice.Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse modelCord blood cytokines and acute lower respiratory illnesses in the first year of lifeConcentrations of IL-15, IL-18, IFN-γ and activity of CD4(+), CD8(+) and NK cells at admission in children with viral bronchiolitis.Cellular and humoral immunity of virus-induced asthmaAsthma: epidemiology, etiology and risk factors.Respiratory syncytial virus--a comprehensive review.Respiratory illness during winter: a cohort study of urban children from temperate Australia.Personal clothing as a potential vector of respiratory virus transmission in childcare settings.Does respiratory syncytial viral-induced bronchiolitis result from helper T cell type 1/type 2 cytokine imbalance?Specific inhibition of type I interferon signal transduction by respiratory syncytial virus.The role of virus-specific immunoglobulin E in airway hyperresponsiveness.Age-related difference in immune responses to respiratory syncytial virus infection in young children.Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection.Soluble adhesion molecules and cytokines in children affected by recurrent infections of the upper respiratory tract.Suppression of IFN-gamma production in atopic group at the acute phase of RSV infection.
P2860
Q26775152-74DBCA68-EB46-464A-ADA8-9730EC4A6985Q33937152-3069DEEE-D6F5-4B32-9484-B5242988B96EQ34416646-E974D51E-58E4-4431-A79F-B634EF34CA0CQ35159747-3D627170-6C2B-42B6-B58D-834F2C816659Q35231239-A5507420-29C5-4C73-8926-DE9B3ADC57EDQ35573501-C86203EB-E649-482F-9602-48B7F11EBFAFQ35897408-C5A0D93A-42F5-49A2-A302-AE63A14EFEC1Q36003444-F4BB483A-2989-4352-A8E0-BB91C1E91330Q36015175-1AB20B8F-9A7A-43A1-BD67-62D140247C43Q36244177-F2751005-024E-4CC7-B6D7-96F21C0E3BD9Q37121841-C9774098-A289-4971-A413-ABB03D4B4544Q37394081-C0652395-BA8B-456B-B959-7CFD5AFD39D9Q38098094-F436BA3C-74F2-46A2-8B3F-AA598DC8F69AQ39711840-70D17BDF-F691-462F-A6D0-6D07ACAFFF4CQ41504902-54C8F0B4-7722-49E1-A479-CDFA913F25E7Q43547623-FF5C7AB2-D497-4841-82F1-174B928A6377Q43839646-483CB40F-4039-452D-9959-EA7854CBE58DQ45015143-C2B06E43-F7C4-4FC8-B0C1-22A11E845224Q45406543-55D0786C-C9ED-4FD8-81EC-83C195D10A70Q45627030-6563F0E7-6147-4293-BCD2-4BCF3FE22593Q48033871-26AF096A-8283-40FC-A320-BDE54B494005Q53611079-561E5413-0F54-4CC3-9F0A-F4B8B8795E8F
P2860
Interferon-gamma levels in nasopharyngeal secretions of infants with respiratory syncytial virus and other respiratory viral infections.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Interferon-gamma levels in nas ...... respiratory viral infections.
@en
Interferon-gamma levels in nas ...... respiratory viral infections.
@nl
type
label
Interferon-gamma levels in nas ...... respiratory viral infections.
@en
Interferon-gamma levels in nas ...... respiratory viral infections.
@nl
prefLabel
Interferon-gamma levels in nas ...... respiratory viral infections.
@en
Interferon-gamma levels in nas ...... respiratory viral infections.
@nl
P2093
P2860
P1476
Interferon-gamma levels in nas ...... respiratory viral infections.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2249.2003.02039.X
P577
2003-01-01T00:00:00Z